Intuitive Surgical Inc (ISRG)
388.51
+5.46
(+1.43%)
USD |
NASDAQ |
May 07, 12:16
Intuitive Surgical Research and Development Expense (TTM): 1.038B for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 1.038B |
December 31, 2023 | 998.80M |
September 30, 2023 | 982.80M |
June 30, 2023 | 950.50M |
March 31, 2023 | 913.40M |
December 31, 2022 | 879.00M |
September 30, 2022 | 818.30M |
June 30, 2022 | 766.70M |
March 31, 2022 | 721.70M |
December 31, 2021 | 671.00M |
September 30, 2021 | 637.40M |
June 30, 2021 | 626.90M |
March 31, 2021 | 607.80M |
December 31, 2020 | 595.10M |
September 30, 2020 | 601.90M |
June 30, 2020 | 582.80M |
March 31, 2020 | 560.40M |
December 31, 2019 | 557.30M |
September 30, 2019 | 520.60M |
June 30, 2019 | 492.30M |
March 31, 2019 | 466.60M |
December 31, 2018 | 418.10M |
September 30, 2018 | 385.30M |
June 30, 2018 | 361.10M |
March 31, 2018 | 350.60M |
Date | Value |
---|---|
December 31, 2017 | 328.60M |
September 30, 2017 | 310.60M |
June 30, 2017 | 289.80M |
March 31, 2017 | 259.90M |
December 31, 2016 | 239.60M |
September 30, 2016 | 223.10M |
June 30, 2016 | 211.50M |
March 31, 2016 | 206.20M |
December 31, 2015 | 197.40M |
September 30, 2015 | 192.10M |
June 30, 2015 | 188.60M |
March 31, 2015 | 179.40M |
December 31, 2014 | 178.00M |
September 30, 2014 | 172.40M |
June 30, 2014 | 168.10M |
March 31, 2014 | 169.10M |
December 31, 2013 | 167.70M |
September 30, 2013 | 167.70M |
June 30, 2013 | 174.20M |
March 31, 2013 | 173.20M |
December 31, 2012 | 170.00M |
September 30, 2012 | 169.70M |
June 30, 2012 | 155.40M |
March 31, 2012 | 147.20M |
December 31, 2011 | 140.20M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
492.30M
Minimum
Jun 2019
1.038B
Maximum
Mar 2024
726.16M
Average
654.20M
Median
Research and Development Expense (TTM) Benchmarks
Abbott Laboratories | 2.771B |
Boston Scientific Corp | 1.444B |
Becton Dickinson & Co | 1.176B |
Alphatec Holdings Inc | 70.12M |
Masimo Corp | 175.20M |